Pfizer Covid booster shot likely to start by Sep 20 in US, says Fauci

The US' booster shot campaign against Covid-19 will likely start with only the Pfizer vaccine from September 20, the country's top infectious disease expert has said

Pfizer Vaccine, Coronavirus vaccine
Photo: Shutterstock
IANS Washington
3 min read Last Updated : Sep 06 2021 | 2:36 PM IST

The US' booster shot campaign against Covid-19 will likely start with only the Pfizer vaccine from September 20, the country's top infectious disease expert has said.

The rollout for Moderna's booster vaccine could, however, be delayed, CNBC news quoted Anthony Fauci as saying on Sunday.

Although both drugmakers have applied to US Food and Drug Administration (FDA) for authorisation of a third dose either six months or eight months after getting the second dose, they haven't been officially approved by the agency.

Even as the approvals are pending, the Joe Biden administration has announced plans to offer third doses to people who received the Pfizer and Moderna shots.

"Only the Pfizer vaccine booster may get FDA and Centers for Disease Control and Prevention (CDC) approval in time for a rollout the week of September 20," Fauci was quoted as saying on CBS' aceFace the Nation."

"Looks like Pfizer has their data in, likely would meet the deadline," the director of the National Institute of Allergy and Infectious Diseases told CBS. "We hope that Moderna would also be able to do it, so we could do it simultaneously."

"But if not, we'll do it sequentially," he continued. aceSo the bottom line is, very likely, at least part of the plan will be implemented, but ultimately the entire plan will be."

He was not in favour of mixing doses and said that for people who got two doses of the Moderna vaccine, "it's better to wait" for a third Moderna dose than get a Pfizer shot, CNN reported.

The booster doses of Pfizer and Moderna doses are based on CDC data that showed protection against infection waned several months after the second shot.

There was good reason to believe that a third dose "will actually be durable, and if it is durable, then you're going to have very likely a three-dose regimen being the routine regimen," Fauci was quoted as saying at a briefing last week.

An FDA advisory panel will review Pfizer's application for a booster on September 17, only three days before shots are supposed to start, the report said.

Meanwhile, the FDA recently amended the emergency use authorisations for the Pfizer-BioNTech and Moderna Covid-19 vaccines to allow the administration of an additional dose to solid organ transplant recipients and other people who have an equivalent level of immunocompromise.

More than 1.3 million such immunocompromised individuals have received an additional shot, according to the CDC.

--IANS

rvt/in

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusPfizerCoronavirus VaccineVaccination

First Published: Sep 06 2021 | 2:36 PM IST

Next Story